NADPH oxidases in the gastrointestinal tract: A potential role of Nox1 in innate immune response and carcinogenesis

Antioxidants and Redox Signaling

Volumn 8, Issue 9-10, 2006, Pages 1573-1582

  Rokutan, Kazuhito ^a   Kawahara, Tsukasa ^a   Kuwano, Yuki ^a   Tominaga, Kumiko ^a   Sekiyama, Atsuo ^a   Teshima Kondo, Shigetada ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; OXIDOREDUCTASE; PROTEIN DUOX2; PROTEIN NOX1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADENOMA; APOPTOSIS; BACTERIAL VIRULENCE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL STRAIN; CELL STRAIN T84; COLON MUCOSA; ENZYME ACTIVATION; ENZYME ACTIVITY; GASTROINTESTINAL TRACT; GUINEA PIG; HELICOBACTER PYLORI; HOST RESISTANCE; HUMAN; INFLAMMATION; INNATE IMMUNITY; MICROBIAL IMMUNITY; MITOGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SALMONELLOSIS; STOMACH EPITHELIUM; TUMOR PROMOTION; UPREGULATION;

ANIMALS; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL TRACT; GUINEA PIGS; HUMANS; IMMUNITY, NATURAL; MODELS, BIOLOGICAL; NADPH OXIDASE; REACTIVE OXYGEN SPECIES;

CAVIA PORCELLUS; HELICOBACTER PYLORI; SALMONELLA ENTERITIDIS;

EID: 33750912209     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2006.8.1573     Document Type: Review

References (79)

1. Akasaki T, Koga H, and Sumimoto H. Phosphoinositide 3-kinase-dependent and -independent activation of the small GTPase Rac2 in human neutrophils. J Biol Chem 274: 18055-18059, 1999.
2. phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem 279: 45935-45941, 2004.
3. 2-generating activity. J Biol Chem 280: 30046-30054, 2005.
4. Arbiser JL, Petros J, Klafter R, Govindajaran B, McLaughlin ER, Brown LF, Cohen C, Moses M, Kilroy S, Arnold RS, and Lambeth JD. Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc Natl Acad Sci U S A 99: 715-720, 2002.
5. Arnold RS, Shi J, Murad E, Whalen AM, Sun CQ, Polavarapu R, Parthasarathy S, Petros JA, and Lambeth JD. Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1. Proc Natl Acad Sci USA. 98: 5550-5555, 2001.
6. Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB. J Clin Invest 107: 241-246, 2001.
7. Banfi B, Clark RA, Steger K, and Krause KH. Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J Biol Chem 278: 3510-3513, 2003.
8. Banfi B, Malgrange B, Knisz J, Steger K, Dubois-Dauphin M, and Krause KH. NOX3, a superoxide-generating NADPH oxidase of the inner ear. J Biol Chem 279: 46065-46072, 2004.
9. 2+-activated NADPH oxidase in testis, spleen, and lymph nodes. J Biol Chem 276: 37594-37601, 2001.
10. Bouma G and Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3: 521-533, 2003.
11. Brar SS, Corbin Z, Kennedy TP, Hemendinger R, Thornton RL, Bommarius B, Arnold RS, Whorton AR, Sturrock AB, Huecksteadt TP, Quinn MT, Krenitsky K, Ardie KG, Lambeth JD, and Hoidal JR. NOX5 NAD(P)H oxidase reglates growth and apoptosis in DU 145 prostate cancer cells. Am J Physiol Cell Physiol 285: C353-C369, 2003.
12. Brar SS, Kennedy TP, Sturrock AB, Huecksteadt TP, Quinn MT, Murphy TM, Chitano P, and Hoidal JR. NADPH oxidase promotes NF-κB activation and proliferation in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 282: L782-L795, 2002.
13. Chang CS, Chen WN, Lin HH, Wu CC, and Wang CJ. Increased oxidative DNA damage, inducible nitric oxide synthase, nuclear factor kappaB expression and enhanced antiapoptosis-related proteins in Helicobacter pylori-infected non-cardiac gastric adenocarcinoma. World J Gastroenterol 10: 2232-2240, 2004.
14. Cheng G and Lambeth JD. NOXO1, regulation of lipid binding, localization, and activation of Nox1 by the Phox homology (PX) domain. J Biol Chem 279: 4737-4742, 2004.
15. Clement MV and Stamenkovic I. Superoxide anion is a natural inhibitor of FAS-mediated cell death. EMBO J 15: 216-225, 1996.
16. rd, and Ozato K. IFN consensus sequence binding protein potentiates STAT1-dependent activation of IFN-γ-responsive promoter in macrophages. Proc Natl Acad Sci U S A 97: 91-96, 2000.
17. Coussens LM and Werb Z. Inflammation and cancer. Nature 420: 860-867, 2002.
18. De Deken X, Wang D, Many MC, Costagliola S, Libert F, Vassart G, Dumont JE, and Miot F. Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem 275: 23227-23233, 2000.
19. Desouki MM, Kulawiec M, Bansal S, Das GM, and Singh KK. Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors. Cancer Biol Ther 4: 1367-1373, 2005.
20. Dikalova A, Clempus R, Lassegue B, Cheng G, McCoy J, Dikalov S, San Martin A, Lyle A, Weber DS, Weiss D, Taylor WR, Schmidt HH, Owens GK, Lambeth JD, and Griendling KK. Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation 112: 2668-2676, 2005.
21. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95, 2002.
22. Dupuy C, Ohayon R, Valent A, Noel-Hudson MS, Dème D, and Virion A. Purification of a novel flavoprotein involved in the thyroid NADPH oxidase. J Biol Chem 274: 37265-37269, 1999.
23. phox expression. J Immunol 163: 6095-6105, 1999.
24. Eklund EA, Luo W, and Skalnik DG. Characterization of three promoter elements and cognate DNA binding protein(s) necessary for IFN-γ induction of gp91-phox transcription. J Immunol 157: 2418-2429, 1996.
25. El Hassani RA, Benfares N, Caillou B, Talbot M, Sabourin JC, Belotte V, Morand S, Gnidehou S, Agnandji D, Ohayon R, Kaniewski J, Noel-Hudson MS, Bidart JM, Schlumberger M, Virion A, and Dupuy C. Dual oxidase2 is expressed all along the digestive tract. Am J Physiol Gastrointest Liver Physiol 288: G933-G942, 2005.
26. Fearon B and Vogelstein ER. A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
27. Fukuyama M, Rokutan K, Sano T, Miyake H, Shimada M, and Tashiro S. Overexpression of a novel superoxide-producing enzyme, NADPH oxidase 1, in adenoma and well differentiated adenocarcinoma of the human colon. Cancer Lett 221: 97-104, 2005.
28. Geiszt M, Dagher MC, Molnar G, Havasi A, Faure J, Paclet MH, Morel F, and Ligeti E. Characterization of membrane-localized and cytosolic Rac-GTPase-activating proteins in human neutrophil granulocytes: contribution to the regulation of NADPH oxidase. Biochem J 355: 851-858, 2001.
29. phox in the regulated production of superoxide by phagocytes. J Immunol 171: 299-306, 2003.
30. phox support superoxide production by NAD(P)H oxidase 1 in colon epithelial cells. J Biol Chem 278: 20006-20012, 2003.
31. Geiszt M and Leto TL. The Nox family of NAD(P)H oxidases: host defence and beyond. J Biol Chem 279: 51715-51718, 2004.
32. Geiszt M, Witta J, Baffi J, Lekstrom K, and Leto TL. Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. FASEB J 17: 1502-1504, 2003.
33. Gewirtz AT, Navas TA, Lyons S, Godowski PJ and Madara JL. Bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immnol 167:1882-1185, 2001.
34. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, Kagnoff MF, and Karin M. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118: 285-296, 2004.
35. Griendling KK, Sorescu D, Lassegue B, and Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arteriosder Thromb Vasc Biol 20: 2175-2183, 2000.
36. Harrison D, Griendling KK, Landmesser U, Hornig B, and Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol 91: 7A-11A, 2003.
37. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett RG, Eng JK, Akira S, Underhill DM, and Aderem A. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410: 1099-1103, 2001.
38. Hershberg RM. The epithelial cell cytoskeleton and intracellular trafficking. V. Polarized compartmentalization of antigen processing and Toll-like receptor signaling in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 283: G833-G839, 2002.
39. Houghton J and Wang TC. Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers. Gastroenterology 128: 1567-1578, 2005.
40. Huber MA, Azoitei N, Baumann B, Grunert S, Sommer A, Pehamberger H, Kraut N, Beug H, and Wirth T. NF-κ B is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 114: 569-581, 2004.
41. Itzkowitz SH and Yio X. Inflammation and cancer IV: colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 287: G7-17, 2004.
42. phox promoter. J Biol Chem 274: 29984-29993, 1999.
43. Jänne PA and Mayer RJ. Chemoprevention of colorectal cancer. N Engl J Med 342: 1960-1968, 2000.
44. Katsuyama M, Fan C, Arakawa N, Nishinaka T, Miyagushi M, Taira K, and Yabe-Nishimura C. Essential role of ATF-1 in induction of NOX1, a catalytic subunit of NADPH oxidase: involvement of mitochondrial respiratory chain. Biochem J 386: 255-261, 2005.
45. Kawahara T, Kohjima M, Kuwano Y, Mino H, Teshima-Kondo S, Takeya R, Tsunawaki S, Wada A, Sumimoto H, and Rokutan K. Helicobacter pylori lipopolysaccharide activates Rac1 and transcription of NADPH oxidase Nox1 and its organizer NOXO1 in guinea pig gastric mucosal cells. Am J Physiol Cell Physiol 288: C450-C457, 2005.
46. Kawahara T, Kuwano Y, Teshima-Kondo S, Takeya R, Sumimoto H, Kishi K, Tsunawaki S, Hirayama T, and Rokutan K. Role of nicotinamide adenine dinucleotide phosphate oxidase 1 in oxidative burst response to toll-like receptor 5 signaling in large intestinal epithelial cells. J Immunol 172: 3051-3058, 2004.
47. phox are dominant inhibitors of Nox1- and Nox2-dependent reactive oxygen generation. J Biol Chem 280: 31859-31869, 2005.
48. Kawahara T, Teshima S, Oka A, Sugiyama T, Kishi K, and Rokutan K. Type I Helicobacter pylori lipopolysaccharide stimulates toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells. Infect Immun 69: 4382-4389, 2001.
49. phox participate in interaction with the small GTPase Rac and activation of the phagocyte NADPH oxidase. J Biol Chem 274: 25051-25060, 1999.
50. 558 heavy chain gene (CYBB) and LINE-1 causes an X-linked chronic granulomatous disease. Genomics 53: 123-128, 1998.
51. phox gene. JBiol Chem 277: 9103-9111, 2002.
52. Kuwano Y, Kawahara T, Yamamoto H, Teshima-Kondo S, Tominaga K, Masuda K, Kishi K, Morita K, and Rokutan K. Interferon-g activates transcription of NADPH oxidase 1 gene and up-regulates production of superoxide anion by human large intestinal epithelial cells. Am J Physiol Cell Physiol 290: C433-C443, 2006.
53. Lambeth JD. Nox/Duox family of nicotinamide adenine dinucleotide (phosphate) oxidases. Curr Opin Hematol 9: 11-17, 2002.
54. Lambeth JD. Nox enzyme and the biology of reactive oxygen. Nat Rev Immunol 4: 181-189, 2004.
55. phox homologues in vascular smooth muscle cells: Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88: 888-894, 2001.
56. Luo W and Skalnik DG. CCAAT displacement protein competes with multiple transcriptional activators for binding to four sites in the proximal gp91phox promoter. JBiol Chem 271: 18203-18210, 1996.
57. Matsuno K, Yamada H, Iwata K, Jin D. Katsuyama M, Matsuki M, Takai S, Yamanishi K, Miyazaki M, Matsubara H, and Yabe-Nishimura C. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation 112: 2677-2685, 2005.
58. Moon SY and Zheng Y. Rho GTPase-activating proteins in cell regulation. Trends Cell Biol 13: 13-22, 2003.
59. Moreno JC, Bikker H, Kempers MJE, Van Trotsenburg P, Baas F, de Vijlder JJM, Vulsma T, and Ris-Stalpers C. Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. N Engl J Med 347: 95-102, 2002.
60. Newburger PE, Skalnik DG, Hopkins PJ, Eklund EA, and Curnutte JT. Mutations in the promoter region of the gene for gp91-phox in X-linked chronic granulomatous disease with decreased expression of cytochrome b558. J Clin Invest 94: 1205-1211, 1994.
61. Paffenholz R, Bergstrom RA, Pasutto F, Wabnitz P, Munroe RJ, Jagla W, Heinzmann U, Marquardt A, Bareiss A, Laufs J, Russ A, Stumm G, Schimenti JC, and Bergstrom DE. Vestibular defects in head-tilt mice result from mutations in Nox3, encoding an NADPH oxidase. Genes Dev 18: 486-491, 2004.
62. 2. Mol Cell Biol 24: 4384-4394, 2004.
63. Peek RM and Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2: 28-37, 2002.
64. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E, and Ben-Neriah Y. NF-κB functions as a tumor promoter in inflammation-associated cancer. Nature 431: 461-466, 2004.
65. Pleskova M, Beck KF, Behrens MH, Huwiler A, Fichtlscherer B, Wingerter O, Brandes RP, Mulsch A, and Pfeilschifter J. Nitric oxide down-regulates the expression of the catalytic NADPH oxidase subunit Nox1 in rat renal mesangial cells. FASEB J 20: 139-141, 2006.
66. Rokutan K, Yamada M, Torigoe J, and Saito T. Transforming growth factor-β inhibits proliferation and maturation of cultured guinea pig gastric pit cells. Am J Physiol Gastrointest Physiol 275: G526-G533, 1998.
67. Salles N, Szanto I, Herrmann F, Armenian B, Stumm M, Stauffer E, Michel J-P, and Krause K-H. Expression of mRNA for ROS-generating NADPH oxidases in the aging stomach. Exp Gerontol 40: 353-357, 2005.
68. Sorescu D, Weiss D, Lassegue B, Clempus RE, Szocs K, Sorescu GP, Valppu L, Quinn MT, Lambeth JD, Vega JD, Taylor WR, and Griendling KK. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105: 1429-1435, 2002.
69. Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK, and Lambeth JD. Cell transformation by the superoxide-generating oxidase Mox1. Nature 401: 19-82, 1999.
70. phox gene in human peripheral neutrophils, monocytes, and B lymphocytes. Proc Natl Acad Sci U S A 95: 6085-6090, 1998.
71. Szanto I, Rubbia-Brandt L, Kiss P, Steger K, Banfi B, Kovari E, Hermann F, and Hadengue A. Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease. J Pathol 207: 164-176, 2005.
72. phox participate in activation of superoxide-producing NADPH oxidases. J Biol Chem 278: 25234-25246, 2003.
73. Teshima S, Kutsumi H, Kawahara T, Kishi K, and Rokutan K. Regulation of growth and apoptosis of cultured guinea pig gastric mucosal cells by mitogen oxidase 1. Am J Physiol Gastrointest Liver Physiol 279: G1169-G1176, 2000.
74. Teshima S, Rokutan K, Nikawa T, and Kishi K. Guinea pig gastric mucosal cells produce abundant superoxide anion through an NADPH oxidase-like system. Gastroenterology 115: 1186-1196, 1998.
75. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N and Schlemper RJ. N Engl J Med 345: 784-789, 2001
76. Ueyama T, Geiszt M, and Leto TL. Involvement of Rac1 in activation of multicomponent Nox1- and Nox3-based NADPH oxidases. Mol Cell Biol 26: 2160-2174, 2006.
77. Welch HC, Coadwell WJ, Stephens LR, and Hawkins PT. Phosphoinositide 3-kinase-dependent activation of Rac. FEBS Lett 546: 93-97, 2003.
78. Wingler K, Wunsch S, Kreutz R, Rothermund L, Paul M, and Schmidt HH. Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic Biol Med 31: 1456-1464, 2001.
79. Yuasa Y. Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer 3: 592-600, 2003.